Multnomah Coma stands out as an exceptionally rare cannabis phenotype, its precise ancestry kept under wraps by breeders. This strain leans toward the indica side, though its exact lineage remains a mystery to the community. Its chemical profile may appeal most to medical users seeking relief, delivering roughly 3% CBD alongside 15 to 16% THC, a combination that signals both analgesic potential and a potent psychoactive lift.
When the effects roll in, a tranquil, uplifting haze first touches the mood, lifting spirits with a gentle, contented euphoria. Soon a heavy, full-bodied sensation follows—a cocoon of relaxation that can verge into substantial lethargy, sometimes to the point of immobility for even seasoned users. Such body-centric relief makes Multnomah Coma a consideration for chronic pain, inflammation, stress, and the insomnia that often accompanies them.
Visually, the buds present as dense, spade-shaped nugs of forest green, threaded with fuzzy orange pistils that resemble tiny caterpillars. The flavor leans sweet and sugary with a citrusy edge and a fruity, earthy aftertaste. Its aroma is similarly bright, merging berry and citrus notes with a pronounced sweetness, and a pungent scent that hints at the plant's indica-forward lineage.